Gastrointestinal manifestations of scleroderma
- PMID: 9891698
- DOI: 10.1016/s0889-8553(05)70021-2
Gastrointestinal manifestations of scleroderma
Abstract
Gastrointestinal involvement is commonly found in scleroderma. Gastrointestinal symptoms may be the presenting symptoms for the diagnosis and may precede the actual diagnosis by months to years. The esophagus is the most frequently affected, but functional problems of the anorectum, small bowel, colon, and stomach may occur. The pathophysiologic mechanism appears to be one of smooth muscle atrophy and, to a lesser degree, fibrosis. These changes result in gastrointestinal motility disturbances and may cause GERD, pseudo-obstruction, bacterial overgrowth, and defecatory disorders. Malnutrition may be a serious consequence. The evaluation of a particular symptom in a patient with scleroderma may lead to treatment strategies that improve the patient's sense of well-being and quality of life.
Similar articles
-
Gastrointestinal manifestations of scleroderma.Rheum Dis Clin North Am. 1996 Nov;22(4):797-823. doi: 10.1016/s0889-857x(05)70302-1. Rheum Dis Clin North Am. 1996. PMID: 8923597 Review.
-
[Digestive localizations of scleroderma].Ann Med Interne (Paris). 1984;135(8):601-5. Ann Med Interne (Paris). 1984. PMID: 6529055 French.
-
[Digestive manifestations in systemic sclerosis].Ann Med Interne (Paris). 2002 Jun;153(4):260-4. Ann Med Interne (Paris). 2002. PMID: 12218892 Review. French.
-
[Digestive symptoms of scleroderma (author's transl)].Ann Dermatol Venereol. 1978 Aug-Sep;105(8-9):725-20. Ann Dermatol Venereol. 1978. PMID: 367249 Review. French.
-
[Gastrointestinal involvement in systemic sclerosis].Presse Med. 2006 Dec;35(12 Pt 2):1952-65. doi: 10.1016/s0755-4982(06)74930-2. Presse Med. 2006. PMID: 17159722 Review. French.
Cited by
-
Assessment of esophageal involvement in systemic sclerosis and morphea (localized scleroderma) by clinical, endoscopic, manometric and pH metric features: a prospective comparative hospital based study.BMC Gastroenterol. 2015 Feb 15;15:24. doi: 10.1186/s12876-015-0241-2. BMC Gastroenterol. 2015. PMID: 25888470 Free PMC article.
-
Functional autoantibodies in systemic sclerosis pathogenesis.Curr Rheumatol Rep. 2015 May;17(5):34. doi: 10.1007/s11926-015-0505-4. Curr Rheumatol Rep. 2015. PMID: 25876754 Review.
-
Impaired rectoanal inhibitory response in scleroderma (systemic sclerosis): an association with fecal incontinence.Dig Dis Sci. 2004 Jun;49(6):1040-5. doi: 10.1023/b:ddas.0000034569.85066.69. Dig Dis Sci. 2004. PMID: 15309898
-
The Videofluorographic Swallowing Study in Rheumatologic Diseases: A Comprehensive Review.Gastroenterol Res Pract. 2017;2017:7659273. doi: 10.1155/2017/7659273. Epub 2017 Jun 15. Gastroenterol Res Pract. 2017. PMID: 28706536 Free PMC article. Review.
-
Recognition and management of scleroderma in children.Paediatr Drugs. 2001;3(8):575-83. doi: 10.2165/00128072-200103080-00002. Paediatr Drugs. 2001. PMID: 11577922 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical